Novel observations in hereditary hemochromatosis: potential implications for clinical strategies.
作者信息
Swinkels Dorine W, Fleming Robert E
出版信息
Haematologica. 2011 Apr;96(4):485-8. doi: 10.3324/haematol.2011.042036.
Abstract
摘要
相似文献
1
Novel observations in hereditary hemochromatosis: potential implications for clinical strategies.遗传性血色素沉着症的新观察结果：对临床策略的潜在影响。
Haematologica. 2011 Apr;96(4):485-8. doi: 10.3324/haematol.2011.042036.
2
Hereditary hemochromatosis--a new look at an old disease.遗传性血色素沉着症——对一种古老疾病的新认识。
N Engl J Med. 2004 Jun 3;350(23):2383-97. doi: 10.1056/NEJMra031573.
3
Molecular insights into the pathogenesis of hereditary haemochromatosis.遗传性血色素沉着症发病机制的分子学见解
Gut. 2006 Apr;55(4):564-8. doi: 10.1136/gut.2005.078063.
4
Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.铁调素：一种与遗传性血色素沉着症和慢性病贫血相关的假定铁调节激素。
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8160-2. doi: 10.1073/pnas.161296298.
5
Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.遗传性铁过载：病理生理学、诊断和治疗的最新进展
Am J Hematol. 2006 Mar;81(3):202-9. doi: 10.1002/ajh.20493.
6
[Molecular basis of hereditary hemochromatosis].[遗传性血色素沉着症的分子基础]
Postepy Hig Med Dosw (Online). 2006;60:217-26.
7
Non-HFE hemochromatosis.非HFE型血色素沉着症
Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
8
[Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].[经典HFE（1型）血色素沉着症的病理生理学与遗传学]
Presse Med. 2007 Sep;36(9 Pt 2):1271-7. doi: 10.1016/j.lpm.2007.03.038. Epub 2007 May 22.
9
Orchestration of iron homeostasis.铁稳态的调控
N Engl J Med. 2005 Apr 28;352(17):1741-4. doi: 10.1056/NEJMp048363.
10
Multifactorial iron man.多因素“钢铁侠” （此翻译可能需结合更具体语境理解其准确含义，这里仅按字面翻译）
Digestion. 2005;72(1):22-4. doi: 10.1159/000087399. Epub 2005 Aug 10.
引用本文的文献
1
The diagnostic potential of the iron-regulatory hormone hepcidin.铁调节激素铁调素的诊断潜力。
Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000236. eCollection 2019 Jun.
2
The Role of Iron and Iron Overload in Chronic Liver Disease.铁及铁过载在慢性肝病中的作用
Med Sci Monit. 2016 Jun 22;22:2144-51. doi: 10.12659/msm.896494.
3
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.血色病或高血铁蛋白症患者的红细胞和纤维蛋白网络的深刻形态变化，以及铁螯合剂和其他药物的正常化。
PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014.
4
Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter.聚（ADP - 核糖）聚合酶 -1（PARP1）通过远端启动子中的反向重复DNA序列对HFE表达的调控。
Biochim Biophys Acta. 2013 Dec;1829(12):1257-1265. doi: 10.1016/j.bbagrm.2013.10.002. Epub 2013 Oct 29.
5
Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study.铁代谢与脂肪细胞胰岛素抵抗和血浆脂联素有关：马斯特里赫特糖尿病和动脉粥样硬化队列（CODAM）研究。
Diabetes Care. 2013 Feb;36(2):309-15. doi: 10.2337/dc12-0505. Epub 2012 Sep 6.
本文引用的文献
1
Mass spectrometry analysis of hepcidin peptides in experimental mouse models.利用质谱分析法分析实验性小鼠模型中的铁调素肽。
PLoS One. 2011 Mar 8;6(3):e16762. doi: 10.1371/journal.pone.0016762.
2
Novel genomic techniques open new avenues in the analysis of monogenic disorders.新型基因组技术为分析单基因疾病开辟了新途径。
Hum Mutat. 2011 Feb;32(2):144-51. doi: 10.1002/humu.21400.
3
Diagnosis and management of hereditary haemochromatosis.遗传性血色素沉着症的诊断与管理
BMJ. 2011 Jan 19;342:c7251. doi: 10.1136/bmj.c7251.
4
Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.初次基因检测时 HFE C282Y 杂合子中的铁过载：一种鉴定罕见 HFE 变异体的策略。
Haematologica. 2011 Apr;96(4):507-14. doi: 10.3324/haematol.2010.029751. Epub 2011 Jan 12.
5
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.铁调素对 HFE 和 TFR2 遗传性血色素沉着症患者铁负荷的时程反应。
Haematologica. 2011 Apr;96(4):500-6. doi: 10.3324/haematol.2010.033449. Epub 2010 Dec 20.
6
Two to tango: regulation of Mammalian iron metabolism.二人探戈：哺乳动物铁代谢的调控。
Cell. 2010 Jul 9;142(1):24-38. doi: 10.1016/j.cell.2010.06.028.
7
EASL clinical practice guidelines for HFE hemochromatosis.EASL 临床实践指南：遗传性血色病
J Hepatol. 2010 Jul;53(1):3-22. doi: 10.1016/j.jhep.2010.03.001. Epub 2010 Apr 18.
8
Non-invasive assessment of tissue iron overload.组织铁过载的无创评估。
Hematology Am Soc Hematol Educ Program. 2009:215-21. doi: 10.1182/asheducation-2009.1.215.
9
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.第一届国际尿和血浆铁调素检测定量测定轮次结果：需要标准化。
Haematologica. 2009 Dec;94(12):1748-52. doi: 10.3324/haematol.2009.010322.
10
Regulation of hepcidin and iron-overload disease.铁调素的调控与铁过载疾病
Annu Rev Pathol. 2009;4:489-515. doi: 10.1146/annurev.pathol.4.110807.092205.
Zotero 插件